| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.1B | $3.4B | $3.5B | $17.2B | $14.0B | $3.5B | $4.5B | $3.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.8B | $0.4B | $0.7B | $1.6B | $3.0B | $0.9B | $1.2B | $0.8B |
| Net Income | $0.6B | $0.1B | $0.3B | $1.0B | $3.3B | $0.7B | $1.0B | $0.6B |
| EPS (Basic) | $0.65 | $0.15 | $0.30 | $1.09 | $3.98 | $0.82 | $1.22 | $0.97 |
| EPS (Diluted) | $0.65 | $0.15 | $0.30 | $1.09 | $3.98 | $0.82 | $1.21 | $0.97 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $115.9B | $102.4B | $109.0B | $104.2B | $99.6B | $95.9B | $103.8B | $77.9B |
| Current Assets | $8.1B | $6.6B | $25.4B | $9.8B | $7.3B | $6.9B | $6.1B | $5.2B |
| Cash & Equivalents | $0.3B | $0.3B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.3B |
| Total Liabilities | $82.4B | $72.2B | $81.5B | $76.4B | $70.7B | $69.4B | $69.8B | $55.9B |
| Current Liabilities | $10.4B | $9.3B | $24.5B | $13.4B | $8.7B | $10.8B | $9.9B | $7.6B |
| Stockholders' Equity | $29.1B | $27.3B | $27.5B | $27.9B | $27.3B | $26.1B | $32.0B | $20.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.4B | $5.0B | $6.6B | $3.7B | $4.0B | $5.2B | $5.2B | $4.8B |
| Investing Cash Flow | $-13.0B | $-3.2B | $-7.2B | $-6.7B | $-6.2B | $-2.9B | $-4.6B | $-2.4B |
| Capital Expenditures | — | — | — | — | — | — | $5.0B | $4.3B |
| Financing Cash Flow | $7.6B | $-1.8B | $0.6B | $3.0B | $2.4B | $-2.3B | $-0.7B | $-2.2B |